Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Cancer Studies > Palliative Care: Constipation/Nausea and Vomiting/SOB/End of Life > Flashcards

Palliative Care: Constipation/Nausea and Vomiting/SOB/End of Life Flashcards

1
Q

Outline some potential causes of constipation.

A
  • Immobility, reduced food intake
  • Reduced fluid intake, fluid loss
  • Generalised weakness
  • Intestinal obstruction e.g. tumour mass
  • Drugs – opioids, diuretics, antimuscarinics, serotonin
    antagonists (antiemetics like Ondansetron), some
    chemotherapy agents + many others!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outline some general measures to managing constipation.

A
  • Maximise mobility
  • Encourage good hydration
  • Assess diet and appetite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List 3 stimulant laxatives.

A
  • Bisacodyl
  • Senna
  • Sodium Picosulphate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List 3 faecal softener.

A
  • Docusate sodium
  • Lactulose (can cause bloating)
  • Macrogols (Laxido, Movicol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List 3 rectal interventions.

A
  • Bisacodyl suppository
  • Glycerol suppository
  • Osmotic micro-enema (Micralax)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List 2 opioid antagonists use for opioid induced constipation.

A
  • Methylnaltrexone (SC injection)

- Naloxegol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List the common causes of nausea/vomiting.

A
  • Drugs: opioids/NSAIDs/SSRIs/TCAs/chemotherapeutic agents
  • Surgical: Bowel obstruction
  • Metabolic: inc. Ca2+/inc. urea/decreased sodium/hypoglycaemia
  • Increased ICP
  • Constipation
  • Anxiety
  • Uncontrolled pain
  • Autonomic neuropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline step 1 of the 4 step antiemetic ladder.

A

Selected narrow spectrum drug e.g. metoclopramide (+/- dexamethasone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Outline step 2 of the 4 step antiemetic ladder.

A

Alternative narrow spectrum drug e.g. haloperidol/cyclizine/ondansetron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline step 3 of the 4 step antiemetic ladder.

A

Combination of narrow spectrum drugs e.g. haloperidol and cyclizine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Outline step 4 of the 4 step antiemetic ladder.

A

Broad spectrum drug e.g. levomepromazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which antiemetic do you use in gastric paresis?

A

Metoclopramide (prokinetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which antiemetic do you use in renal failure?

A

Haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which antiemetic do you use in chemotherapy?

A

Ondansetron + dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which antiemetic do you use in intestinal obstruction?

A

Cyclizine (+/- haloperidol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which antiemetic do you use in unclear/multiple causes?

A

Levomepromazine (broad spectrum)

17
Q

Mechanism of action of metoclopramide?

A

Dopamine (D2) receptor antagonist at chemoreceptor trigger zone at medulla oblongata - preventing nausea and vomiting triggered by most stimuli. Gastric prokinetic effect mediated by muscarininc, D2 antagonism, and 5HT4 receptor agonism (may contribute to antiemetic effect)

18
Q

Mechanism of action of ondansetron?

A

Ondansetron is a highly specific and selective serotonin 5-HT3 receptor antagonist, with low affinity for dopamine receptors. The 5-HT3 receptors are present both peripherally on vagal nerve terminals and centrally in the CTZ.

Serotonin is released by the enterochromaffin cells of the small intestine in response to chemotherapeutic agents and may stimulate vagal afferents (via 5-HT3 receptors) to initiate the vomiting reflex. It is thought that ondansetron’s antiemetic action is mediated mostly via antagonism of vagal afferents with a minor contribution from antagonism of central receptors.

19
Q

Mechanism of action of cyclizine?

A
  • H1 receptor antagonist (antihistamine)
  • Not fully elucidated
  • Effects on vestibular system and CTZ
  • Also exerts central anticholinergic (muscarinic) effects
20
Q

Mechanism of action of haloperidol?

A
  • High affinity for dopamine D2 receptor (antagonist) - acts at CTZ of MO.
21
Q

Mechanism of action of levomepromazine?

A
  • Broad spectrum
  • D2 receptor antagonism
  • H1 receptor antagnosim
  • Acetylcholine muscarinic receptor antagonism
22
Q

Outline the side-effects of metoclopramide.

A
  1. Extrapyramidal side-effects:
    - Akathisia (restlessness)
    - Focal dystonia (the “yips”/spasms)
    - Tardive dyskinesia (D2 Rx antagonism e.g. lip smacking/sticking tongue out/rapid blinking)
  2. Abdominal cramps
23
Q

Outline the side-effects of haloperidol.

A
  1. Extrapyramidal side-effects:
    - Akathisia (restlessness)
    - Focal dystonia (the “yips”/spasms)
    - Tardive dyskinesia (D2 Rx antagonism e.g. lip smacking/sticking tongue out/rapid blinking)
  2. Sedation
24
Q

Outline the side-effects of ondansetron.

A
  • Constipation

- Headache

25
Q

Outline the side-effects of dexamethasone.

A

Hyperglycaemia, oral candida, GI ulcers,

Psychiatric disturbance + many more!

26
Q

Outline the side-effects of cyclizine.

A
  • Anti-muscarinic side-effects (e.g. drowsiness/dry mouth/diplopia/urinary retention/constipation).
  • Sedation
27
Q

Outline the side-effects of levomepromazine.

A
  1. Extrapyramidal side-effects:
    - Akathisia (restlessness)
    - Focal dystonia (the “yips”/spasms)
    - Tardive dyskinesia (D2 Rx antagonism e.g. lip smacking/sticking tongue out/rapid blinking)
  2. Sedation
28
Q

What is dyspnoea?

A

Dyspnoea is a feeling of difficult or laboured breathing which is out of proportion to the level of physical activity

29
Q

Where is normal breathing maintained?

A

Maintained by respiratory centre in brainstem

30
Q

List causes of dyspnoea.

A
  • Lymphadenopathy
  • Carcinoma +/- SVCO
  • Mesothelioma
  • Heart failure, arrhythmias, pericardial effusion
  • Pulmonary fibrosis
  • COPD/asthma
  • PE, pneumonia, collapse, consolidation
  • Muscle weakness (diaphragm)
  • Metastasis
  • Pleural effusion
  • Anaemia/uraemia/acidosis
31
Q

Outline 1st line dyspnoea management in palliative care.

A
  • Open window, handheld fan
  • Relaxation therapy
  • OT – teach breathing techniques
  • Cognitive behavioral therapy
  • Advice on adapting daily activities
32
Q

Outline 2nd line dyspnoea management in palliative care.

A
  • MST 5mg BD or Oramorph 2mg 4hrly
  • Work by reducing CNS respiratory drive
  • Care re: too much RR depression
33
Q

Outline the 3rd line dyspnoea management in palliative care.

A

+/- Benzodiazepines
Lorazepam 0.5 – 1mg QDS PRN
Care re: CNS depression
Will only treat anxiety; not dyspnoea itself

34
Q

Outline clinical scenarios where syringe drivers are used.

A

Reliable 24hr SC medication delivery when PO route
ineffective due to:
- Intractable vomiting
- Severe dysphagia (so unable to swallow)
- Poor GI absorption
- Poor patient compliance
- Decreased level of consciousness in the dying patient

NB/ good practice to switch back to PO if and when appropriate

35
Q

List the common end of life care (EOLC) symptoms.

A
  • Upper respiratory tract secretions (‘death rattle’)
  • Pain
  • Restlessness/agitation
  • Incontinence
  • Dyspnoea
  • Urinary retention
  • Sweating
  • Nausea
  • Delirium
36
Q

How is delirium relieved in patient at end of life?

A
  • Haloperidol/Levomepromazine

- Midazolam

37
Q

What are some possible signs of imminent death?

A
  • Cheyne-stoke respiration
  • Mottled skin
  • Loss of consciousness
  • Retained upper respiratory secretions – if present reassure family/visitors that rarely causes patient distress (often worry about choking)
  • All or none may be present
38
Q

Outline the end of life care PRN medication (anticipatory prescribing).

A

The 5 A’s:

  • Analgesic – an Opioid
     E.g. Morphine sulphate 2 – 5mg SC 4hrly PRN (dose should reflect background opioid dose)
  • Antiemetic
     E.g. Levomepromazine 5 – 10mg SC 4hrly PRN
  • Anxiolytic
     E.g. Midazolam 2 – 5mg SC 4hrly PRN
  • Anti-secretory
     E.g. Glycopyrronium 200mcg SC 4hrly PRN
  • +/- Anti-seizure
     E.g. Midazolam 10mg IM

Cancer Studies (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions